TPIDB > 臨床試驗主持人
臨床試驗主持人
更新時間：2023-09-19
邵幼雲SHAO, YU-YUN
- 計畫主持人
- 執行臨床試驗年資 17 年 9 個月
發表文獻
83筆
1
Yu-Yun Shao, Ann-Lii Cheng, Chih-Hung Hsu. An Underdiagnosed Hypothyroidism and Its Clinical Significance in Patients with Advanced Hepatocellular Carcinoma. The Oncologist 2021 (early E-published)#
2
Yi-Ping Hung, Yu-Yun Shao, Chiun Hsu, Chih-Hung Hsu, Jan-Mou Lee, Muh-Hwa Yang, Yee Chao. The unique characteristic in peripheral immune cells in patients with advanced hepatocellular carcinoma. Journal of the Formosan Medical Association 2020 (early E-published)#
3
Yu-Yun Shao and Hung-Ju Lin. Correspondence to: Management of Venous Thromboembolisms: Part II. The Consensus for Pulmonary Embolism and Updates. Acta Cardiologica Sinica 2021 Mar; 37: 213-214 (corresponding author)#
4
Yu-Yun Shao*, Shen-Yung Wang*, Diagnosis Group, and Systemic Therapy Group. Management Consensus Guideline for Hepatocellular Carcinoma: 2020 Update on Surveillance, Diagnosis, and Systemic Treatment by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan. Journal of the Formosan Medical Association 2021 Apr; 120: 1051-1060 (*co-first authors)#
5
Yu-Yun Shao, Wen-Ying Lin, Chih-Peng Lin, Li-Chun Lu, Chih-Hung Hsu. Solving the Deficit of Cancer Pain Management Skills by Education Programs. Supportive Care in Cancer 2021 Apr; 29: 1843-1848 (corresponding author)#
6
Yi-Ping Hung, Yu-Yun Shao, Jan-Moug Lee, Chiun Hus, Chih-Hung Hsu, Muh-Hwa Yang, Yee, Chao. Potential of Circulating Immune Cells as Biomarkers of Nivolumab Treatment Efficacy for Advanced Hepatocellular Carcinoma. Journal of the Chinese Medical Association 2021 Feb; 84: 144-150.
7
Chih-Horng Wu, Po-Chin Liang, Chih-Hung Hsu, Fang-Tsu Chang, Yu-Yun Shao, Tiffany Ting-Fang Shih. Total Skeletal, Psoas and Rectus Abdominis Muscle Mass as Prognostic Factors for Patients with Advanced Hepatocellular Carcinoma. Journal of the Formosan Medical Association 2021 Jan; 120: 559-566 (corresponding author)#
8
Tsung-Hao Liu, Yu-Yun Shao, Chih-Hung Hsu. It Takes Two to Tango: Breakthrough Advanced Hepatocellular Carcinoma Treatment that Combines Anti-Angiogenesis and Immune Checkpoint Blockade. Journal of the Formosan Medical Association 2021 Jan; 120: 1-4#
9
Zhong‐Zhe Lin, Bang‐Bin Chen, Yi‐Ping Hung, Po‐Hsiang Huang, Ying‐Chun Shen, Yu‐Yun Shao, Chih‐Hung Hsu, Ann‐Lii Cheng, Rheun‐Chuan Lee, Yee Chao, Chiun Hsu. A Multicenter Phase II Study of Second‐Line Axitinib for Patients with Advanced Hepatocellular Carcinoma Failing First‐Line Sorafenib Monotherapy. The Oncologist 2020 Apr; 25:1-6.#
10
Johnson Lin, Ruey‐Kuen Hsieh, Jen‐Shi Chen, Kuan‐Der Lee, Kun‐Ming Rau, Yu‐Yun Shao, Yung‐Chuan Sung, Su‐Peng Yeh, Cheng‐Shyong Chang, Ta‐Chih Liu, Ming‐Fang Wu, Ming‐Yang Lee, Ming‐Sun Yu, Chia‐Jui Yen, Pang‐Yu Lai, Wen‐Li Hwang, Tzeon‐Jye Chiou. Satisfaction with Pain Management and Impact of Pain on Quality of Life in Cancer Patients. Asia-Pacific Journal of Clinical Oncology 2020 Apr; 16: e91-98
